Medable has reached its 100th trial, signaling a new era in clinical trials, one that democratizes patient access by removing the barriers posed by geography. Today’s trials offer sponsors and CROs new opportunities to improve time to treatment and realize operational efficiencies across R&D using a new set of unified patient-focused digital approaches.
However, how sponsors choose to deploy these tools is key in realizing efficiencies.
Join Medable’s Executive VP of Life Sciences Tyler Pugsley, Digital Endpoint GM Gillian Livock, and Chief Design Officer Sina Mossayeb as they share lessons learned and best practices from their time spent modernizing trials with flexible, modular, and seamless decentralized solutions. Attendees will walk away with an understanding of:
Tyler Pugsley, Medable’s Vice President of Life Sciences has almost a decade of experience partnering with pharmaceutical sponsors and...